Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Neuren Pharmaceuticals Limited has announced a daily update on its ongoing on-market buy-back program, revealing that 37,029 ordinary shares were repurchased on the previous day, contributing to a total of 561,507 shares bought back to date. This strategic move is aimed at enhancing shareholder value by reducing the number of outstanding shares. Investors interested in Neuren’s financial activities may find this development noteworthy.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
